N-terminal acetylation of melanophore-stimulating hormone in the pars intermedia of Xenopus laevis is a physiologically regulated process.
The N-terminal acetylation of melanophore-stimulating hormone (MSH) increases the melanotropic potency of the peptide. This modification may be important in amphibians, where MSH causes skin darkening during adaptation to black background. This study examines the acetylation status of the peptide in the toad Xenopus laevis under different conditions of background adaptation. Acetylated and nonacetylated alpha-MSH were analyzed by high-performance liquid chromatography and quantified by radioimmunoassay. The acetylation status of alpha-MSH was analyzed in tissue, in plasma and in media obtained from in vitro incubation of neurointermediate lobe tissue. Nonacetylated MSH is the major form of alpha-MSH in tissue from both black- and white-background-adapted animals. In plasma of black-adapted animals only acetylated alpha-MSH could be detected. Plasma MSH levels of white-adapted animals were barely detectable. Analysis of peptides secreted during in vitro incubations of neurointermediate lobe tissue from black-adapted animals showed that the relative contribution of alpha-MSH to the immunoreactive profile was considerably enhanced, which supports the concept that acetylation of MSH in Xenopus is associated with the secretory process. Acetylation capacity of tissue from white-adapted animals was much lower and only after several days on black background was full capacity acquired. It is suggested that de novo biosynthesis of acetylation enzymes may be necessary for the acquisition of the acetylation capacity. Transfer of black animals to white background caused a rapid decrease in acetylation capacity, which suggests that factors involved in the rapid inhibition of secretion might also regulate acetylation.(ABSTRACT TRUNCATED AT 250 WORDS)
Verburg-van Kemenade
B M
BM
Department of Zoology, Faculty of Science, Nijmegen, The Netherlands.
Jenks
B G
BG
Smits
R J
RJ
D000107:Acetylation; D000222:Adaptation, Physiological; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004298:Dopamine / Q000494:pharmacology; D066298:In Vitro Techniques; D009074:Melanocyte-Stimulating Hormones / Q000097:blood / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D011863:Radioimmunoassay; D014982:Xenopus laevis; D000521:alpha-MSH / Q000031:analogs & derivatives / Q000378:metabolism
D010446:Peptide Fragments; D000521:alpha-MSH; D009074:Melanocyte-Stimulating Hormones; D004298:Dopamine